(UPDATE) Daratumumab
CAR T-Cell Therapies: Idecabtagene Vicleucel and Ciltacabtagene Autoleucel
Elotuzumab
Teclistamab-cqyv
The Leukemia and Lymphoma Society
Multiple Myeloma Research Foundation (MMRF)
NCCN Virtual Reimbursement Resource Room
International Myeloma Foundation (IMF)